Aspira Pathlab & Diagnostics Ltd. Hits Lower Circuit on BSE, 28 October 2026

The exchange sets a band around each stock’s previous close, and on 28 October 2026 Aspira Pathlab & Diagnostics Ltd. went straight to the lower edge of it. The Aspira Pathlab & Diagnostics lower circuit price on BSE was Rs 118.75, which is 5% below the previous close of Rs 125.

The company’s market cap is Rs 128.66 crore. Sellers dominated from the first trade, and the shares were still at the floor when this note was written.

Key Takeaways

• Aspira Pathlab & Diagnostics Ltd. (ASPIRA) hit the lower circuit on BSE at Rs 118.75 on 28 October 2026.
• The session move was -5% against a previous close of Rs 125.
• Market capitalisation stood at Rs 128.66 crore with a PE ratio of 53.63.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Trading began at Rs 118.75, the same level as the high and the low for the day, so the session had no range at all: the price opened on the band and stayed there on BSE, against a previous close of Rs 125.

The decline in rupees was Rs 6.25, matching the 5% move. The numbers are all from BSE, so the open, the range and the reference close can be compared directly.

A band is calculated per exchange, which is why a second venue could show different reference figures and why this note holds to one. For the session the limit was Rs 118.75, and the price never moved off it.

Why Aspira Pathlab & Diagnostics Ltd. Hit Lower Circuit

Aspira Pathlab & Diagnostics Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the lower circuit level of Rs 118.75.

What the Aspira Pathlab & Diagnostics Lower Circuit Means

Each trading day the exchange draws a floor under a stock, and a lower circuit is the price arriving at that floor. For Aspira Pathlab & Diagnostics Ltd., the floor in force on 28 October 2026 was Rs 118.75.

Bands are there to blunt abrupt swings and keep trading orderly. The limit for any later session is set by the exchange afresh, so this one says nothing about it; it records how the market is structured and where the band was reached today.

Aspira Pathlab & Diagnostics Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Aspira Pathlab & Diagnostics Ltd., PE ratio was 53.63, PB ratio was 10.18, book value was Rs 12.28, EPS was 2.33, ROE was 18.13%, ROCE was 19.27%, dividend yield was 0% and debt-to-assets ratio was 0.1, on a market cap of Rs 128.66 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 10.18, the market valued Aspira Pathlab & Diagnostics Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Aspira Pathlab & Diagnostics Ltd. belongs to the Hospital & Healthcare Services industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Several of these peers are far larger by market capitalisation than Aspira Pathlab & Diagnostics Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Aspira Pathlab & Diagnostics Ltd.’s PE ratio was 53.63, compared with an available peer PE average of 30.64, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 53.31, the 50-day moving average was 123.66 and the 200-day moving average was 103.79.

What Readers Should Know

The confirmed record is brief: Aspira Pathlab & Diagnostics Ltd. was held at the lower circuit price of Rs 118.75 on BSE on 28 October 2026, with a -5% day move.

Getting out is the practical difficulty. Sellers are stacked at the band and takers are few, so an exit at the quoted price may not be possible. The other gap is the lack of a confirmed official catalyst at the time of writing.

The event is a market update and not a standalone investment conclusion. The band does point to heavy near-term selling, but any follow-up needs business fundamentals, valuation, liquidity, risk and confirmed company disclosures beside it.

Frequently Asked Questions

Why did Aspira Pathlab & Diagnostics Ltd. hit lower circuit on 28 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was ASPIRA share price on 28 October 2026?

The last traded price used in this article was Rs 118.75 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for ASPIRA?

The lower circuit price was Rs 118.75. The stated exchange lower circuit limit was Rs 118.75. The event numbers in this article are aligned to BSE.

What is Aspira Pathlab & Diagnostics Ltd.’s market cap and PE ratio?

Aspira Pathlab & Diagnostics Ltd.’s market cap was Rs 128.66 crore. PE ratio was 53.63.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting a lower circuit mean Aspira Pathlab & Diagnostics Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Aspira Pathlab & Diagnostics Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Aspira Pathlab & Diagnostics Ltd. the stated limit was Rs 118.75. For this session, Aspira Pathlab & Diagnostics Ltd. moved -5%.